Data as of Mar 14
| -0.57 / -3.24%|
The 4 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 30.00, with a high estimate of 38.00 and a low estimate of 30.00. The median estimate represents a +76.16% increase from the last price of 17.03.
The current consensus among 5 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.